指南与共识心血管CTDSA

基于冠状动脉CT血管造影的SYNTAX评分II治疗推荐对多支冠状动脉病变进行无创心脏团队评估:随机SYNTAX III Revolution试验的设计与原理

Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial.
指南 / 共识 · EuroIntervention · 2017-01-01

SYNTAX III Revolution试验为前瞻性、多中心、全纳入随机试验,将两个心脏团队随机分配至基于有创常规血管造影或无创多层螺旋CT血管造影的评估,依据SYNTAX评分II选择外科或经皮血运重建策略。主要终点为两种评估方式下初始血运重建方式决策的kappa一致度,次要终点包括需治疗血管数和需血运重建冠状动脉节段的一致度。

要点

  • 试验对比无创MSCT与有创血管造影指导心脏团队血运重建决策的一致性。
  • 治疗选择由SYNTAX评分II计算引导,主要终点为决策kappa一致度。
  • 次要终点包括需治疗血管数和需血运重建冠状动脉节段的一致度。

核心结论

  • SYNTAX III Revolution试验将为纯无创冠状动脉解剖评估能否准确选择多支冠状动脉病变患者最合适的血运重建策略提供有价值的信息。

研究设计与样本

  • 前瞻性、多中心、全纳入随机试验,将两个心脏团队随机分配至基于有创常规血管造影或无创MSCT血管造影评估,依据SYNTAX评分II选择外科或经皮治疗。

诊断标准与关键数值

  • 主要终点为心脏团队基于MSCT与血管造影评估的初始血运重建方式决策的kappa一致度;次要终点包括需治疗血管数和需血运重建冠状动脉节段的一致度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS: The aim of this study was to investigate whether a Heart Team decision-making process regarding the choice of revascularisation strategy based on non-invasive coronary multislice computed tomography angiography (MSCT) assessment of coronary artery disease (CAD) is equivalent to the standard-of-care invasive angiography-based assessment in patients with multivessel CAD.

METHODS AND RESULTS: The SYNTAX III Revolution trial is a prospective, multicentre, all-comers randomised trial that will randomise two Heart Teams to select between surgical and percutaneous treatment according to either an invasive conventional angiography or a non-invasive MSCT angiography assessment in patients with multivessel CAD. The treatment selection by each Heart Team will be guided by the SYNTAX score II calculation. The primary endpoint is the level of agreement according to kappa of the initial decision by the Heart Teams on the modality of the revascularisation based on MSCT and angiography assessments. Secondary endpoints include agreement on the number of vessels requiring treatment and the coronary segments in need of revascularisation.

CONCLUSIONS: The SYNTAX III Revolution trial will provide valuable information regarding the ability of a purely non-invasive coronary anatomy assessment to select accurately the most appropriate revascularisation strategy for patients with multivessel CAD.

来源:EuroIntervention,查看原文。版权归原作者所有。

引用

  1. Cavalcante R, Onuma Y, Sotomi Y, et al. Non-invasive Heart Team assessment of multivessel coronary disease with coronary computed tomography angiography based on SYNTAX score II treatment recommendations: design and rationale of the randomised SYNTAX III Revolution trial. EuroIntervention. 2017. PMID: 27973335. doi:10.4244/EIJ-D-16-00612

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。